Back to Journals » Core Evidence » Volume 6

ESCI
SJR OA

Core Evidence


        

Archive: Volume 6, 2011

Review

Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes

Barnett AH

Core Evidence 2011, 6:67-79

Published Date: 8 September 2011

Review

Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review

Kirkby S, Novak K, McCoy K

Core Evidence 2011, 6:59-66

Published Date: 11 August 2011

Review

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Jain S, Diefenbach C, Zain J, O'Connor OA

Core Evidence 2011, 6:43-57

Published Date: 4 April 2011

Review

Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes

Bernardo Lombo, José G Díez

Core Evidence 2011, 6:31-42

Published Date: 17 March 2011

Review

Plerixafor for autologous CD34+ cell mobilization

Huda Salman, Hillard M Lazarus

Core Evidence 2011, 6:23-29

Published Date: 8 February 2011

Review

Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis

Emilio Portaccio

Core Evidence 2011, 6:13-21

Published Date: 6 January 2011

Review

Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma

Brian Poligone, Janet Lin, Catherine Chung

Core Evidence 2011, 6:1-12

Published Date: 22 December 2010